Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors

The objective of this study was to identify potential predictors of immune-related adverse events (irAEs) in cancer patients receiving immune checkpoint inhibitor therapy among serum indexes, case data, and li...
Source: BMC Immunology - Category: Allergy & Immunology Authors: Tags: Research Source Type: research